Abdera Therapeutics is a clinical-stage biopharmaceutical company focused on developing precision radiopharmaceuticals for cancer
Abdera Therapeutics is a clinical-stage biopharmaceutical company focused on developing precision radiopharmaceuticals for cancer. The company utilizes its proprietary Radio Optimized Vector Engineering (ROVEr™) platform to engineer antibody-based therapies that deliver potent radioisotopes to solid tumors, aiming to maximize therapeutic effect while minimizing systemic toxicity.